Fig. 2From: Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment PlansInitial Consensus Treatment Plan (CTP) Choice By Site. CTP choices distributed by site, showing that 4 sites started only a non-biologic CTP (red colors), while 8 sites started only a biologic CTP (blue colors), IL1i: IL1 inhibitor; IL6i: IL6 inhibitorBack to article page